FDA OKs Aflibercept (Eylea) for Diabetic Retinopathy

The VEGF inhibitor is already approved for neovascular (wet) age-related macular degeneration, macular edema after central retinal vein occlusion, and diabetic macular edema.
FDA Approvals

Full Story →